Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

Pfizer expects full-year earnings in the range of $2.80 to $3 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...

American architecture studio Gensler has revealed designs for an office-to-residential conversion of the former Pfizer ...

U.S. drugmaker Pfizer beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strong sales of its heart ...

Investors have been cool to Pfizer, with shares down some 50% since record highs in 2021. Pfizer Chief Executive Albert Bourla has been looking to turn around the company's performance, taking steps ...

U.S. stock futures were trading lower on Tuesday after Monday's decline as the new administration tariffs continued to spook ...

Pfizer challenges the status quo by introducing ... old Florida golfer who scored a hole in one, and a piece in the New York Times about snacking and exercise, shared under the caption 'Now ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Real-time index price for DJ All Metals CC Index (BAMC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for S&P 500 Index (INX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.

US pharma giant Pfizer reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial ...